ArticleBMC cancer2024

The efficacy and safety of tislelizumab combined with gemcitabine plus cisplatin in the treatment of postoperative patients with muscle-invasive upper tract urothelial carcinoma.

Jingwen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.